Patents expiring in 2030

US 7825102

Treatment of dry eye conditions

CAN-FITE BIOPHARMA LTD. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7824681

Human monoclonal antibodies that specifically bind IGF-II

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7824680

Methods for inhibiting angiogenesis

The Regents of the University of California · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825150

Compositions and methods for treating immunological and inflammatory diseases and disorders

LEXICON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825142

Heterocyclic compounds, compositions comprising them and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825127

Method for treating cancer

Takeda Pharmaceutical Company Limited · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825092

Dendroaspis natriuretic peptide for treatment of cancer

United States Department of Veteran Affairs · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825126

Purine derivatives as A3 and A1 adenosine receptor agonists

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825116

N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825278

Substituted enaminones, their derivatives and uses thereof

The Regents of the University of California · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825096

O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825231

Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7824697

High concentration baclofen preparations

The Board of Regents of the University of Texas System · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7824682

Cardiac myosin light chain kinase-specific antibodies and methods of detecting

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7824690

Marek's disease virus vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825265

Compounds with activity at estrogen receptors

ACADIA Pharmaceuticals Inc. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825269

Ligands for nematode nuclear receptors and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825216

Phenylanine derivatives

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825159

Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof

UNITED COLOR MANUFACTURING, INC. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825136

Potentiators of antibacterial activity

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7824695

Delivery of proteins across polar epithelial cell layers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825242

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7825154

Small molecule inhibitors of botulinum neurotoxins

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829102

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829712

Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

Xenon Pharmaceuticals Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829583

Biphenyl derivatives

Theravance, Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829561

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829279

Compositions and methods for diagnosis and treatment of epilepsy

The Regents of the University of California · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829074

Hydroxypatite-targeting poly(ethylene glycol) and related polymers

Nektar Therapeutics · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829304

Compounds and related methods for mutant p53 reactivation

Northwestern University · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829503

Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents

PTC THERAPEUTICS, INC. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829533

Cyclosporin analog formulations

Isotechnika, Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829668

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829688

Peptides of CaV2.2 that inhibit pain

The Board of Regents of the University of Texas System · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829723

Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829693

Compositions and methods for inhibiting expression of a target gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829728

Diarymethyl and related compounds

Theravance, Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7829081

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

HALOZYME, INC. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834051

Cyclic amine compounds

Takeda Pharmaceutical Company Limited · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834041

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834150

Isolated cold-and-menthol-sensitive receptor (CMR1)

The Regents of the University of California · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834185

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834138

Segmented polymers and their conjugates

Nektar Therapeutics · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834200

Processes and intermediates

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834000

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834005

Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834024

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834035

Allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)